Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) is ramping higher Monday after announcing a new CFO, which has some thinking "buyout."

This article: 100 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE